ABDX — Abingdon Health Cashflow Statement
0.000.00%
Last trade - 00:00- £12.48m
- £11.49m
- £4.05m
Annual cashflow statement for Abingdon Health, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.26 | -3.37 | -6.97 | -21.3 | -3.45 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.031 | 3.87 | 1.47 | 9.79 | -0.344 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.233 | 1.38 | -8.12 | -5.09 | 3.95 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.908 | 2.1 | -12.9 | -7.74 | 0.914 |
| Capital Expenditures | -0.096 | -1.66 | -6.83 | -0.76 | -0.157 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.017 | -0.278 | -0.443 | 0.004 | 0.089 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.079 | -1.94 | -7.28 | -0.756 | -0.068 |
| Financing Cash Flow Items | — | — | 0.009 | -0.119 | -0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.38 | 3.37 | 20.7 | 5.92 | -0.007 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.389 | 3.52 | 0.589 | -2.58 | 0.839 |